Increased rate of formation of small-sized platelet aggregates in patients with acute coronary syndromes

Japanese Circulation Journal

Volumn 64, Issue 9, 2000, Pages 647-652

  Miyamoto, S ^a   Ogawa, H ^a   Soejima, H ^a   Takazoe, K ^a   Kajiwara, I ^a   Sakamoto, T ^a   Yoshimura, M ^a   Kugiyama, K ^a   Yasue, H ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndromes; Laser light scattering method; Platelet aggregability

Indexed keywords

ACETYLSALICYLIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LIGHT SCATTERING; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ASPIRIN; COHORT STUDIES; COMPARATIVE STUDY; CORONARY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SCATTERING, RADIATION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0033813638     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.647     Document Type: Article

References (31)

1. The pathogenesis of coronary artery disease and acute coronary syndromes
2. Molecular bases of acute coronary syndromes
3. Coronary plaque disruption
4. Increased plasma fibrinopeptide A levels during attacks induced by hyperventilation in patients with coronary vasospastic angina
5. Fibrinopeptide A is released into the coronary circulation after coronary spasm
6. Circadian variation of plasma fibrinopeptide A level in patients with variant angina
7. Fibrinopeptide A: A marker of coronary thrombosis
8. Fibrinopeptide A and platelet factor levels in unstable angina pectoris
9. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction
10. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina
11. Circadian variation in fibrinolytic activity in patients with variant angina
12. Circulating aggregated platelets, number of platelet per aggregate, and platelet size during acute myocardial infarction
13. Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial (Thrombolysis in Myocardial Infarction)
14. Increased neutrophil-platelet adhesion in patients with unstable angina
15. Aggregation of blood platelets by adenosine diphosphate and its reversal
16. Critical evaluation of platelet aggregation in whole human blood
17. Detection of platelet aggregates with a particle counting method using light scattering
18. Factors that affect the size of platelet aggregates in epinephrine-induced activation: A study using the particle counting method based on light scattering
19. Platelet aggregation in acute coronary syndromes: Use of a new aggregometer with laser scattering to assess platelet aggregability
20. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm
21. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death
22. Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association
23. Coronary angioscopic findings in the infarct-related vessel within I month of acute myocardial infarction
24. Formation of platelet aggregates after attacks of coronary spastic angina pectorals
25. Platelet hyperreactivity and prognosis in survivors of myocardial infarction
26. Enhanced shear-induced platelet aggregation in acute myocardial infarction
27. Rapid change of platelet aggregability in acute hyperglycemia: Detection by a novel laser-light scattering method
28. Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: Correlation with spontaneous aggregation
29. Development of large platelet aggregates from small aggregates as determined by laser-light scattering: Effect of aggregant concentration and antiplatelet medication
30. The mechanism of the effect of aspirin on human platelets: I. Acetylation of a particulate fraction protein
31. Ticlopidine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states